Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jan 15;101(2):398–405. doi: 10.1172/JCI1117

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

R Ciubotariu 1, Z Liu 1, A I Colovai 1, E Ho 1, S Itescu 1, S Ravalli 1, M A Hardy 1, R Cortesini 1, E A Rose 1, N Suciu-Foca 1
PMCID: PMC508579  PMID: 9435312

Abstract

The role of the indirect allorecognition pathway in acute allograft rejection has been documented both in organ recipients and in experimental models. However, it is unknown whether self-restricted recognition of donor alloantigens also contributes to chronic allograft rejection. The aim of this study was to determine the relationship between allopeptide reactivity, epitope spreading, and chronic rejection. Using synthetic peptides corresponding to the hypervariable region of 32 HLA-DR alleles, we have followed the specificity of self-restricted T cell alloresponses to the donor in a population of 34 heart allograft recipients. T cells from sequential samples of blood collected from the patients up to 36 mo after transplantation were studied in limiting dilution analysis for allopeptide reactivity. The incidence of coronary artery vasculopathy (CAV) was significantly higher in patients who displayed persistent alloreactivity late after transplantation than in patients who showed no alloreactivity after the first 6 mo after transplantation. Both intra- and intermolecular spreading of epitopes was observed with an increased frequency in patients developing CAV in less than 2 yr, compared with patients without CAV; this suggests that diversification of the immune response against the graft contributes to chronic rejection. These data provide a strategy for identifying patients at risk of developing CAV and a rationale for therapeutic intervention aimed to prevent the progression of the rejection process.

Full Text

The Full Text of this article is available as a PDF (220.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen M. D., McDonald T. O., Carlos T., Himes V., Fishbein D., Aziz S., Gordon D. Endothelial adhesion molecules in heart transplantation. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S8–13. [PubMed] [Google Scholar]
  2. Benichou G., Fedoseyeva E. V. The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol. 1996;13(3):231–243. doi: 10.3109/08830189609061750. [DOI] [PubMed] [Google Scholar]
  3. Benichou G., Fedoseyeva E., Lehmann P. V., Olson C. A., Geysen H. M., McMillan M., Sercarz E. E. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J Immunol. 1994 Aug 1;153(3):938–945. [PubMed] [Google Scholar]
  4. Bradley J. A. Indirect T cell recognition in allograft rejection. Int Rev Immunol. 1996;13(3):245–255. doi: 10.3109/08830189609061751. [DOI] [PubMed] [Google Scholar]
  5. Braun M. Y., McCormack A., Webb G., Batchelor J. R. Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance. Eur J Immunol. 1993 Jul;23(7):1462–1468. doi: 10.1002/eji.1830230710. [DOI] [PubMed] [Google Scholar]
  6. Casten L. A., Pierce S. K. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J Immunol. 1988 Jan 15;140(2):404–410. [PubMed] [Google Scholar]
  7. Clayton J. P., Gammon G. M., Ando D. G., Kono D. H., Hood L., Sercarz E. E. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med. 1989 May 1;169(5):1681–1691. doi: 10.1084/jem.169.5.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Colovai A. I., Molajoni E. R., Cortesini R., Suciu-Foca N. New approaches to specific immunomodulation in transplantation. Int Rev Immunol. 1996;13(3):161–172. doi: 10.3109/08830189609061745. [DOI] [PubMed] [Google Scholar]
  9. Costanzo-Nordin M. R. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S90–103. [PubMed] [Google Scholar]
  10. Demetris A. J., Zerbe T., Banner B. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc. 1989 Aug;21(4):3667–3669. [PubMed] [Google Scholar]
  11. Elson C. J., Barker R. N., Thompson S. J., Williams N. A. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today. 1995 Feb;16(2):71–76. doi: 10.1016/0167-5699(95)80091-3. [DOI] [PubMed] [Google Scholar]
  12. Fenoglio J., Ho E., Reed E., Rose E., Smith C., Reemstma K., Marboe C., Suciu-Foca N. Anti-HLA antibodies and heart allograft survival. Transplant Proc. 1989 Feb;21(1 Pt 1):807–809. [PubMed] [Google Scholar]
  13. Foegh M. L. Eicosanoids and platelet activating factor mechanisms in organ rejection. Transplant Proc. 1988 Dec;20(6):1260–1263. [PubMed] [Google Scholar]
  14. Frist W. H., Oyer P. E., Baldwin J. C., Stinson E. B., Shumway N. E. HLA compatibility and cardiac transplant recipient survival. Ann Thorac Surg. 1987 Sep;44(3):242–246. doi: 10.1016/s0003-4975(10)62062-0. [DOI] [PubMed] [Google Scholar]
  15. Gallon L., Watschinger B., Murphy B., Akalin E., Sayegh M. H., Carpenter C. B. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation. 1995 Feb 27;59(4):612–616. [PubMed] [Google Scholar]
  16. Gordon D. Growth factors and cell proliferation in human transplant arteriosclerosis. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S7–S7. [PubMed] [Google Scholar]
  17. Harris P. E., Liu Z., Suciu-Foca N. MHC class II binding of peptides derived from HLA-DR 1. J Immunol. 1992 Apr 1;148(7):2169–2174. [PubMed] [Google Scholar]
  18. Hosenpud J. D., Morris T. E., Shipley G. D., Mauck K. A., Wagner C. R. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation. 1996 Mar 27;61(6):939–948. doi: 10.1097/00007890-199603270-00017. [DOI] [PubMed] [Google Scholar]
  19. Häyry P., Mennander A., Yilmaz S., Ustinov J., Räisänen A., Miettinen A., Lautenschlager I., Lemström K., Bruggeman C. A., Paavonen T. Towards understanding the pathophysiology of chronic rejection. Clin Investig. 1992 Sep;70(9):780–790. doi: 10.1007/BF00180748. [DOI] [PubMed] [Google Scholar]
  20. Häyry P., Paavonen T., Mennander A., Ustinov J., Räisänen A., Lemström K. Pathophysiology of allograft arteriosclerosis. Transplant Proc. 1993 Apr;25(2):2070–2070. [PubMed] [Google Scholar]
  21. Häyry P. Pathophysiology of chronic rejection. Transplant Proc. 1996 Dec;28(6 Suppl 1):7–10. [PubMed] [Google Scholar]
  22. Jenkins M. K., Pardoll D. M., Mizuguchi J., Chused T. M., Schwartz R. H. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5409–5413. doi: 10.1073/pnas.84.15.5409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985 Apr 11;314(6011):537–539. doi: 10.1038/314537a0. [DOI] [PubMed] [Google Scholar]
  24. Lechler R. I., Heaton T., Barber L., Bal V., Batchelor J. R., Lombardi G. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett. 1992 Sep;34(1):63–69. doi: 10.1016/0165-2478(92)90028-m. [DOI] [PubMed] [Google Scholar]
  25. Lechler R. I., Lombardi G., Batchelor J. R., Reinsmoen N., Bach F. H. The molecular basis of alloreactivity. Immunol Today. 1990 Mar;11(3):83–88. doi: 10.1016/0167-5699(90)90033-6. [DOI] [PubMed] [Google Scholar]
  26. Lehmann P. V., Sercarz E. E., Forsthuber T., Dayan C. M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993 May;14(5):203–208. doi: 10.1016/0167-5699(93)90163-F. [DOI] [PubMed] [Google Scholar]
  27. Liu Z., Colovai A. I., Tugulea S., Reed E. F., Fisher P. E., Mancini D., Rose E. A., Cortesini R., Michler R. E., Suciu-Foca N. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest. 1996 Sep 1;98(5):1150–1157. doi: 10.1172/JCI118898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liu Z., Harris P. E., Colovai A. I., Reed E. F., Maffei A., Suciu-Foca N. Indirect recognition of donor MHC Class II antigens in human transplantation. Clin Immunol Immunopathol. 1996 Mar;78(3):228–235. doi: 10.1006/clin.1996.0034. [DOI] [PubMed] [Google Scholar]
  29. Mamula M. J., Janeway C. A., Jr Do B cells drive the diversification of immune responses? Immunol Today. 1993 Apr;14(4):151–154. doi: 10.1016/0167-5699(93)90274-O. [DOI] [PubMed] [Google Scholar]
  30. Mason P. D., Robinson C. M., Lechler R. I. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int. 1996 Sep;50(3):1019–1025. doi: 10.1038/ki.1996.404. [DOI] [PubMed] [Google Scholar]
  31. McRae B. L., Vanderlugt C. L., Dal Canto M. C., Miller S. D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 1995 Jul 1;182(1):75–85. doi: 10.1084/jem.182.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Quill H., Schwartz R. H. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol. 1987 Jun 1;138(11):3704–3712. [PubMed] [Google Scholar]
  33. Reed E. F., Hong B., Ho E., Harris P. E., Weinberger J., Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 1996 Feb 27;61(4):566–572. doi: 10.1097/00007890-199602270-00009. [DOI] [PubMed] [Google Scholar]
  34. Rose E. A., Pepino P., Barr M. L., Smith C. R., Ratner A. J., Ho E., Berger C. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S120–S123. [PubMed] [Google Scholar]
  35. Rose E. A., Smith C. R., Petrossian G. A., Barr M. L., Reemtsma K. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery. 1989 Aug;106(2):203–208. [PubMed] [Google Scholar]
  36. Sayegh M. H., Carpenter C. B. Role of indirect allorecognition in allograft rejection. Int Rev Immunol. 1996;13(3):221–229. doi: 10.3109/08830189609061749. [DOI] [PubMed] [Google Scholar]
  37. Sayegh M. H., Carpenter C. B. Role of indirect allorecognition in allograft rejection. Int Rev Immunol. 1996;13(3):221–229. doi: 10.3109/08830189609061749. [DOI] [PubMed] [Google Scholar]
  38. Sercarz E. E., Lehmann P. V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 1993;11:729–766. doi: 10.1146/annurev.iy.11.040193.003501. [DOI] [PubMed] [Google Scholar]
  39. Sercarz E., Krzych U. The distinctive specificity of antigen-specific suppressor T cells. Immunol Today. 1991 Apr;12(4):111–118. doi: 10.1016/0167-5699(91)90094-A. [DOI] [PubMed] [Google Scholar]
  40. Smith J. D., Rose M. L., Pomerance A., Burke M., Yacoub M. H. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet. 1995 Nov 18;346(8986):1318–1322. doi: 10.1016/s0140-6736(95)92341-1. [DOI] [PubMed] [Google Scholar]
  41. Stinson E. B., Griepp R. B., Payne R., Dong E., Jr Correlation of histocompatibility matching with graft rejection and survival after cardiac transplantation in man. Lancet. 1971 Aug 28;2(7722):459–461. doi: 10.1016/s0140-6736(71)92629-8. [DOI] [PubMed] [Google Scholar]
  42. Suciu-Foca N., Reed E., Marboe C., Harris P., Yu P. X., Sun Y. K., Ho E., Rose E., Reemtsma K., King D. W. The role of anti-HLA antibodies in heart transplantation. Transplantation. 1991 Mar;51(3):716–724. doi: 10.1097/00007890-199103000-00033. [DOI] [PubMed] [Google Scholar]
  43. Thyberg J., Hedin U., Sjölund M., Palmberg L., Bottger B. A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990 Nov-Dec;10(6):966–990. doi: 10.1161/01.atv.10.6.966. [DOI] [PubMed] [Google Scholar]
  44. Tugulea S., Ciubotariu R., Colovai A. I., Liu Z., Itescu S., Schulman L. L., Fisher P. E., Hardy M. A., Rose E. A., Michler R. E. New strategies for early diagnosis of heart allograft rejection. Transplantation. 1997 Sep 27;64(6):842–847. doi: 10.1097/00007890-199709270-00009. [DOI] [PubMed] [Google Scholar]
  45. Vanderlugt C. J., Miller S. D. Epitope spreading. Curr Opin Immunol. 1996 Dec;8(6):831–836. doi: 10.1016/S0952-7915(96)80012-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vidard L., Rock K. L., Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J Immunol. 1992 Sep 15;149(6):1905–1911. [PubMed] [Google Scholar]
  47. Wagner C. R., Morris T. E., Shipley G. D., Hosenpud J. D. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest. 1993 Sep;92(3):1269–1277. doi: 10.1172/JCI116699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Watschinger B., Gallon L., Carpenter C. B., Sayegh M. H. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation. 1994 Feb 27;57(4):572–576. [PubMed] [Google Scholar]
  49. Yoshikawa M., Watanabe M., Hozumi N. Analysis of proteolytic processing during specific antigen presentation. Cell Immunol. 1987 Dec;110(2):431–435. doi: 10.1016/0008-8749(87)90135-3. [DOI] [PubMed] [Google Scholar]
  50. Yu M., Johnson J. M., Tuohy V. K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med. 1996 Apr 1;183(4):1777–1788. doi: 10.1084/jem.183.4.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H. L., Hafler D. A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med. 1994 Mar 1;179(3):973–984. doi: 10.1084/jem.179.3.973. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES